Excellos
La Rochelle, France
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
59.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Excellos
- Signal Score
- 59.0/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- La Rochelle, France
- Modalities
- Cell Therapy, CAR-T
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Excellos
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy, CAR-T
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: La Rochelle, FR
Modalities: Cell Therapy, CAR-T
Capacity assessment: 58.0/100
Sites: La Rochelle, FR
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: La Rochelle, FR
Modalities: Cell Therapy, CAR-T
Capacity assessment: 58.0/100
Hiring Activity 3 open roles Beta
From public job postings on Excellos' careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
3
open roles
3
in manufacturing, quality, PD/MSAT, engineering or regulatory (100%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 0 new postings, 0 taken down.
By function
By site
San Diego, CA
1 mfg/ops · 2 QA/QC 3
1 mfg/ops · 2 QA/QC 3
Modality words in job titles
Cell therapy / CAR-T2
Latest postings
QC Analyst II
Quality (QA / QC) · San Diego, CA
Cell Therapy Quality Assurance Specialist
Quality (QA / QC) · San Diego, CA
Cell Therapy Manufacturing Associate II
Manufacturing & operations · San Diego, CA
Coverage: counted from Excellos' own careers board.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
ats.rippling.com
· Checked Nov 20, 2026 · Tracking since Oct 26, 2026
Frequently Asked Questions About Excellos
What is Excellos's CDMO Signal Score?
Excellos has a Signal Score of 59/100, based on quality, operations, financial stability, and capacity data.
Evaluating Excellos for a manufacturing program?
Use the free AI matchmaker to compare Excellos against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 87.0
CAR-T, Cell Therapy
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 84.0
CAR-T, Cell Therapy
Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score: 83.1
CAR-T, Cell Therapy
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 82.7
CAR-T, Cell Therapy, AAV, ADC, Monoclonal Antibody
Compare Excellos with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.